Respiratory symptoms in young adults and future lung disease the cardia lung study

Ravi Kalhan; Mark T. Dransfield; Laura A. Colangelo; Michael J. Cuttica; David R. Jacobs; Bharat Thyagarajan; Raul San Jose Estepar; Rola Harmouche; Jorge Onieva Onieva; Samuel Y. Ash; Yuka Okajima; Carlos Iribarren; Stephen Sidney; Cora E. Lewis; David M. Mannino; Kiang Liu; Lewis J. Smith; George R. Washko

doi:10.1164/rccm.201710-2108OC

Respiratory symptoms in young adults and future lung disease the cardia lung study

Ravi Kalhan, Mark T. Dransfield, Laura A. Colangelo, Michael J. Cuttica, David R. Jacobs, Bharat Thyagarajan, Raul San Jose Estepar, Rola Harmouche, Jorge Onieva Onieva, Samuel Y. Ash, Yuka Okajima, Carlos Iribarren, Stephen Sidney, Cora E. Lewis, David M. Mannino, Kiang Liu, Lewis J. Smith, George R. Washko

Research output: Contribution to journal › Article › peer-review

65 Scopus citations

Abstract

Rationale: There are limited data on factors in young adulthood that predict future lung disease. Objectives: To determine the relationship between respiratory symptoms, loss of lung health, and incident respiratory disease in a population-based study of young adults. Methods:Weexamined prospective data from2,749 participants in the CARDIA (Coronary Artery Risk Development in Young Adults) study who completed respiratory symptom questionnaires at baseline and 2 years later and repeated spirometry measurements over 30 years. Measurements and Main Results: Cough or phlegm, episodes of bronchitis, wheeze, shortness of breath, and chest illnesses at both baseline and Year 2 were the main predictor variables in models assessing decline in FEV1 and FVC from Year 5 to Year 30, incident obstructive and restrictive lung physiology, and visual emphysema on thoracic computed tomography scan. After adjustment for covariates, including body mass index, asthma, and smoking, report of any symptom was associated with22.71 ml/yr excess decline in FEV1 (P, 0.001) and22.18 in FVC (P,0.001) aswell as greater odds of incident (prebronchodilator) obstructive (odds ratio [OR], 1.63; 95% confidence interval [CI], 1.24-2.14) and restrictive (OR, 1.40; 95% CI, 1.09-1.80) physiology. Cough-related symptoms (OR, 1.56; 95% CI, 1.13-2.16) were associated with greater odds of future emphysema. Conclusions: Persistent respiratory symptoms in young adults are associated with accelerated decline in lung function, incident obstructive and restrictive physiology, and greater odds of future radiographic emphysema.

Original language	English (US)
Pages (from-to)	1616-1624
Number of pages	9
Journal	American journal of respiratory and critical care medicine
Volume	197
Issue number	12
DOIs	https://doi.org/10.1164/rccm.201710-2108OC
State	Published - Jun 15 2018

Bibliographical note

Funding Information:
University of Alabama at Birmingham, grants HHSN268201300025C and HHSN268201300026C

Funding Information:
The CARDIA (Coronary Artery Risk Development in Young Adults) study is conducted and supported by the NHLBI in collaboration with the University of Alabama at Birmingham, grants HHSN268201300025C and HHSN268201300026C, Northwestern University grant HHSN268201300027C, University of Minnesota grant HHSN268201300028C, Kaiser Foundation Research Institute grant HHSN268201300029C, and Johns Hopkins University School of Medicine grant HHSN268200900041C. CARDIA is also partially supported by the Intramural Research Program of the National Institute on Aging and an intra-agency agreement between the National Institute on Aging and NHLBI, grant AG0005. Additional funding was provided by NHLBI grant R01 HL122477 (CARDIA Lung Study). This manuscript has been reviewed by CARDIA for scientific content.

Publisher Copyright:
Copyright © 2018 by the American Thoracic Society.

Keywords

Chronic obstructive pulmonary disease
Respiratory epidemiology
Respiratory function tests
Respiratory symptoms

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1164/rccm.201710-2108OC

OpenUrl availability

Full text

Cite this

Kalhan, R., Dransfield, M. T., Colangelo, L. A., Cuttica, M. J., Jacobs, D. R., Thyagarajan, B., Estepar, R. S. J., Harmouche, R., Onieva, J. O., Ash, S. Y., Okajima, Y., Iribarren, C., Sidney, S., Lewis, C. E., Mannino, D. M., Liu, K., Smith, L. J., & Washko, G. R. (2018). Respiratory symptoms in young adults and future lung disease the cardia lung study. American journal of respiratory and critical care medicine, 197(12), 1616-1624. https://doi.org/10.1164/rccm.201710-2108OC

Kalhan, R, Dransfield, MT, Colangelo, LA, Cuttica, MJ, Jacobs, DR , Thyagarajan, B, Estepar, RSJ, Harmouche, R, Onieva, JO, Ash, SY, Okajima, Y, Iribarren, C, Sidney, S, Lewis, CE, Mannino, DM, Liu, K, Smith, LJ & Washko, GR 2018, 'Respiratory symptoms in young adults and future lung disease the cardia lung study', American journal of respiratory and critical care medicine, vol. 197, no. 12, pp. 1616-1624. https://doi.org/10.1164/rccm.201710-2108OC

@article{bb5fdfdf9587422a94b0639fd76833e4,

title = "Respiratory symptoms in young adults and future lung disease the cardia lung study",

abstract = "Rationale: There are limited data on factors in young adulthood that predict future lung disease. Objectives: To determine the relationship between respiratory symptoms, loss of lung health, and incident respiratory disease in a population-based study of young adults. Methods:Weexamined prospective data from2,749 participants in the CARDIA (Coronary Artery Risk Development in Young Adults) study who completed respiratory symptom questionnaires at baseline and 2 years later and repeated spirometry measurements over 30 years. Measurements and Main Results: Cough or phlegm, episodes of bronchitis, wheeze, shortness of breath, and chest illnesses at both baseline and Year 2 were the main predictor variables in models assessing decline in FEV1 and FVC from Year 5 to Year 30, incident obstructive and restrictive lung physiology, and visual emphysema on thoracic computed tomography scan. After adjustment for covariates, including body mass index, asthma, and smoking, report of any symptom was associated with22.71 ml/yr excess decline in FEV1 (P, 0.001) and22.18 in FVC (P,0.001) aswell as greater odds of incident (prebronchodilator) obstructive (odds ratio [OR], 1.63; 95% confidence interval [CI], 1.24-2.14) and restrictive (OR, 1.40; 95% CI, 1.09-1.80) physiology. Cough-related symptoms (OR, 1.56; 95% CI, 1.13-2.16) were associated with greater odds of future emphysema. Conclusions: Persistent respiratory symptoms in young adults are associated with accelerated decline in lung function, incident obstructive and restrictive physiology, and greater odds of future radiographic emphysema.",

keywords = "Chronic obstructive pulmonary disease, Respiratory epidemiology, Respiratory function tests, Respiratory symptoms",

author = "Ravi Kalhan and Dransfield, {Mark T.} and Colangelo, {Laura A.} and Cuttica, {Michael J.} and Jacobs, {David R.} and Bharat Thyagarajan and Estepar, {Raul San Jose} and Rola Harmouche and Onieva, {Jorge Onieva} and Ash, {Samuel Y.} and Yuka Okajima and Carlos Iribarren and Stephen Sidney and Lewis, {Cora E.} and Mannino, {David M.} and Kiang Liu and Smith, {Lewis J.} and Washko, {George R.}",

note = "Funding Information: University of Alabama at Birmingham, grants HHSN268201300025C and HHSN268201300026C Funding Information: The CARDIA (Coronary Artery Risk Development in Young Adults) study is conducted and supported by the NHLBI in collaboration with the University of Alabama at Birmingham, grants HHSN268201300025C and HHSN268201300026C, Northwestern University grant HHSN268201300027C, University of Minnesota grant HHSN268201300028C, Kaiser Foundation Research Institute grant HHSN268201300029C, and Johns Hopkins University School of Medicine grant HHSN268200900041C. CARDIA is also partially supported by the Intramural Research Program of the National Institute on Aging and an intra-agency agreement between the National Institute on Aging and NHLBI, grant AG0005. Additional funding was provided by NHLBI grant R01 HL122477 (CARDIA Lung Study). This manuscript has been reviewed by CARDIA for scientific content. Publisher Copyright: Copyright {\textcopyright} 2018 by the American Thoracic Society.",

year = "2018",

month = jun,

day = "15",

doi = "10.1164/rccm.201710-2108OC",

language = "English (US)",

volume = "197",

pages = "1616--1624",

journal = "American journal of respiratory and critical care medicine",

issn = "1073-449X",

publisher = "American Thoracic Society",

number = "12",

}

TY - JOUR

T1 - Respiratory symptoms in young adults and future lung disease the cardia lung study

AU - Kalhan, Ravi

AU - Dransfield, Mark T.

AU - Colangelo, Laura A.

AU - Cuttica, Michael J.

AU - Jacobs, David R.

AU - Thyagarajan, Bharat

AU - Estepar, Raul San Jose

AU - Harmouche, Rola

AU - Onieva, Jorge Onieva

AU - Ash, Samuel Y.

AU - Okajima, Yuka

AU - Iribarren, Carlos

AU - Sidney, Stephen

AU - Lewis, Cora E.

AU - Mannino, David M.

AU - Liu, Kiang

AU - Smith, Lewis J.

AU - Washko, George R.

N1 - Funding Information: University of Alabama at Birmingham, grants HHSN268201300025C and HHSN268201300026C Funding Information: The CARDIA (Coronary Artery Risk Development in Young Adults) study is conducted and supported by the NHLBI in collaboration with the University of Alabama at Birmingham, grants HHSN268201300025C and HHSN268201300026C, Northwestern University grant HHSN268201300027C, University of Minnesota grant HHSN268201300028C, Kaiser Foundation Research Institute grant HHSN268201300029C, and Johns Hopkins University School of Medicine grant HHSN268200900041C. CARDIA is also partially supported by the Intramural Research Program of the National Institute on Aging and an intra-agency agreement between the National Institute on Aging and NHLBI, grant AG0005. Additional funding was provided by NHLBI grant R01 HL122477 (CARDIA Lung Study). This manuscript has been reviewed by CARDIA for scientific content. Publisher Copyright: Copyright © 2018 by the American Thoracic Society.

PY - 2018/6/15

Y1 - 2018/6/15

N2 - Rationale: There are limited data on factors in young adulthood that predict future lung disease. Objectives: To determine the relationship between respiratory symptoms, loss of lung health, and incident respiratory disease in a population-based study of young adults. Methods:Weexamined prospective data from2,749 participants in the CARDIA (Coronary Artery Risk Development in Young Adults) study who completed respiratory symptom questionnaires at baseline and 2 years later and repeated spirometry measurements over 30 years. Measurements and Main Results: Cough or phlegm, episodes of bronchitis, wheeze, shortness of breath, and chest illnesses at both baseline and Year 2 were the main predictor variables in models assessing decline in FEV1 and FVC from Year 5 to Year 30, incident obstructive and restrictive lung physiology, and visual emphysema on thoracic computed tomography scan. After adjustment for covariates, including body mass index, asthma, and smoking, report of any symptom was associated with22.71 ml/yr excess decline in FEV1 (P, 0.001) and22.18 in FVC (P,0.001) aswell as greater odds of incident (prebronchodilator) obstructive (odds ratio [OR], 1.63; 95% confidence interval [CI], 1.24-2.14) and restrictive (OR, 1.40; 95% CI, 1.09-1.80) physiology. Cough-related symptoms (OR, 1.56; 95% CI, 1.13-2.16) were associated with greater odds of future emphysema. Conclusions: Persistent respiratory symptoms in young adults are associated with accelerated decline in lung function, incident obstructive and restrictive physiology, and greater odds of future radiographic emphysema.

AB - Rationale: There are limited data on factors in young adulthood that predict future lung disease. Objectives: To determine the relationship between respiratory symptoms, loss of lung health, and incident respiratory disease in a population-based study of young adults. Methods:Weexamined prospective data from2,749 participants in the CARDIA (Coronary Artery Risk Development in Young Adults) study who completed respiratory symptom questionnaires at baseline and 2 years later and repeated spirometry measurements over 30 years. Measurements and Main Results: Cough or phlegm, episodes of bronchitis, wheeze, shortness of breath, and chest illnesses at both baseline and Year 2 were the main predictor variables in models assessing decline in FEV1 and FVC from Year 5 to Year 30, incident obstructive and restrictive lung physiology, and visual emphysema on thoracic computed tomography scan. After adjustment for covariates, including body mass index, asthma, and smoking, report of any symptom was associated with22.71 ml/yr excess decline in FEV1 (P, 0.001) and22.18 in FVC (P,0.001) aswell as greater odds of incident (prebronchodilator) obstructive (odds ratio [OR], 1.63; 95% confidence interval [CI], 1.24-2.14) and restrictive (OR, 1.40; 95% CI, 1.09-1.80) physiology. Cough-related symptoms (OR, 1.56; 95% CI, 1.13-2.16) were associated with greater odds of future emphysema. Conclusions: Persistent respiratory symptoms in young adults are associated with accelerated decline in lung function, incident obstructive and restrictive physiology, and greater odds of future radiographic emphysema.

KW - Chronic obstructive pulmonary disease

KW - Respiratory epidemiology

KW - Respiratory function tests

KW - Respiratory symptoms

UR - http://www.scopus.com/inward/record.url?scp=85049052858&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049052858&partnerID=8YFLogxK

U2 - 10.1164/rccm.201710-2108OC

DO - 10.1164/rccm.201710-2108OC

M3 - Article

C2 - 29369684

AN - SCOPUS:85049052858

SN - 1073-449X

VL - 197

SP - 1616

EP - 1624

JO - American journal of respiratory and critical care medicine

JF - American journal of respiratory and critical care medicine

IS - 12

ER -

Respiratory symptoms in young adults and future lung disease the cardia lung study

Abstract

Bibliographical note

Keywords

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this